Skip to main content
. Author manuscript; available in PMC: 2015 Mar 10.
Published in final edited form as: Pediatr Diabetes. 2009 Dec 8;11(3):166–174. doi: 10.1111/j.1399-5448.2009.00550.x

Table 3.

Pretest to posttest comparisons (N = 12, df = 11)

Measure Means SD t p
Benefits Ex 1 4.157 0.536 1.431 0.18
Benefits Ex 2 3.935 0.511
Barriers Ex 1 2.525 0.602 −1.116 0.29
Barriers Ex 2 2.758 0.493
Ex self-efficacy 1 3.792 0.640 0.593 0.57
Ex self-efficacy 2 3.677 0.741
DSSQ-F Ex normative 1 2.119 1.473 −2.496 0.03*
DSSQ-F Ex normative 2 3.000 1.365
DSSQ-F Ex individualized 1 4.179 4.253 1.955 0.08
DSSQ-F Ex individualized 2 6.357 4.576
DQOL worries 1 1.86 0.61 −0.516 0.62
DQOL worries 2 1.76 0.39
DQOL impact 1 2.19 0.39 −0.299 0.77
DQOL impact 2 2.15 0.43
DQOL satisfaction 1 3.73 0.51 0.803 0.44
DQOL satisfaction 2 3.85 0.63
Health 1 2.83 0.58 0.561 0.59
Health 2 3.00 0.85
Relative VO2peak (mL/Kg/min) 1 33.28 6.95 1.686 0.12
Relative VO2peak (mL/Kg/min) 2 35.84 8.80
Absolute VO2peak (L/min) 1 2.18 0.47 1.247 0.24
Absolute VO2peak (L/min) 2 2.30 0.46
A1c (%) 1 9.40 1.83 0.018 0.99
A1c (%) 2 9.39 2.05

Pretest and posttest values are indicated by (1) and (2), respectively.

*

p < 0.05.